Successful management of denture-associated candidiasis relies heavily on mechanical disinfection rather than pharmacologic ...

ReSTORE trial met both primary endpoints and demonstrated non-inferiority of rezafungin versus current standard of care, caspofungin1 Rezafungin demonstrated high mycological efficacy rates in initial ...

A case report of a patient with acute leukemia who developed chronic disseminated candidiasis revealed difficulties in diagnosing and treating the illness. Proper care and an accurate diagnosis were ...

These agents—the echinocandins caspofungin, anidulafungin, and micafungin—are essentially reserved for candidemia and other invasive forms of candidiasis. The Guidelines also incorporate new data on ...

While most people recover from fungal infections like candidiasis, it can pose a serious risk for immuno-compromised patients ...

– REZZAYO is a novel, once-weekly, next-generation echinocandin indicated for the treatment of candidemia and invasive candidiasis in adults with limited or no alternative treatment options – – ...

What is Candida auris? The superbug experts say is spreading around the world - Strains from the invasive yeast fungus are resistant to treatment ...

Oral thrush, or oral candidiasis, is a common fungal infection that can significantly impact oral health and overall well-being. This article will delve into how oral thrush develops, its symptoms, ...

Approval based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and extensive nonclinical development program. REZZAYO ...

Drug-resistant Candida auris can withstand most disinfectants and can remain within a person's body for weeks, experts say.

SAN DIEGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (CDTX), a biotechnology company developing therapies designed to save lives and improve the standard of care for patients facing ...